Back to NewsPublished: 9 Feb 2026Download AppJoin TelegramWhy Novo Nordisk’s 8% Surge Could Signal a New Growth Wave – Watch the FDA Ripple Effect#Novo Nordisk#pharma#GLP-1#stock market#investment#weight loss drugsDownload AppJoin CommunityShare Article